RepliCel Life Sciences's total assets for Q2 2025 were C$22.32K, a decrease of -0.93% from the previous quarter. REPCF total liabilities were C$1.20M for the fiscal quarter, a 2.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.